Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Therapy for nosocomial pneumonia

R G Wunderink1

  • 1University of Tennessee at Memphis 38105, USA.

Current Opinion in Pulmonary Medicine
|March 1, 1997
PubMed
Summary

Antibiotic therapy for ventilator-associated pneumonia (VAP) needs refinement. Quantitative cultures improve outcomes, suggesting current empiric antibiotic choices are often inadequate for VAP treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety and efficacy of multipotent adult progenitor cells in acute respiratory distress syndrome (MUST-ARDS): a multicentre, randomised, double-blind, placebo-controlled phase 1/2 trial.

Intensive care medicine·2021
Same author

Impact of macrolide therapy on mortality for patients with severe sepsis due to pneumonia.

The European respiratory journal·2008
Same author

A diplotype in the lymphotoxin alpha gene is associated with differential expression of LTA mRNA induced by Gram-positive and Gram-negative bacteria.

International journal of immunogenetics·2007
Same author

[Stakes, treatment strategies and progression of MRSA nosocomial pneumonia, especially pneumonia due to mechanical ventilation].

Presse medicale (Paris, France : 1983)·2004
Same author

Effect of clopidogrel on bleeding after coronary artery bypass surgery.

Critical care medicine·2002
Same author

Controversies in the diagnosis of ventilator-acquired pneumonia.

The Medical clinics of North America·2001

Area of Science:

  • Critical Care Medicine
  • Infectious Diseases
  • Pulmonology

Background:

  • The American Thoracic Society issued guidelines for nosocomial pneumonia antibiotic therapy due to limited clinical trials.
  • Multicenter studies and specific pathogen reports revealed both the utility and limitations of these ATS-recommended therapies for ventilator-associated pneumonia (VAP).

Purpose of the Study:

  • To evaluate the current antibiotic therapy recommendations for ventilator-associated pneumonia (VAP).
  • To assess the impact of diagnostic methods and specific pathogens on VAP treatment efficacy.

Main Methods:

  • Review of a consensus statement on nosocomial pneumonia.
  • Analysis of multicenter studies on VAP antibiotic therapy modification.
  • Examination of studies on Pseudomonas VAP and anaerobic copathogens.
  • Meta-analysis of aminoglycoside dosing and aerosolization.
  • Decision-analysis modeling for VAP antibiotic treatment strategies.
  • Comparison of bronchoscopic and nonbronchoscopic quantitative cultures for VAP diagnosis.

Main Results:

  • ATS-recommended therapies for VAP showed both appropriateness and inadequacies.
  • Anaerobic pathogens were identified in early-onset VAP but had minimal impact on antibiotic choices.
  • Once-daily aminoglycoside dosing and aerosolization showed potential treatment improvements.
  • Decision analysis suggested withholding antibiotics based on clinical diagnosis could increase mortality.
  • Quantitative cultures for VAP diagnosis improved outcomes, identifying inappropriate empiric antibiotics in ~40% of late-onset cases.

Conclusions:

  • Current empiric antibiotic therapy for VAP, particularly late-onset, is frequently inappropriate.
  • Quantitative culture-guided antibiotic selection improves patient outcomes in VAP.
  • Refined diagnostic and therapeutic strategies are crucial for optimizing VAP management.

Related Experiment Videos